TABLE 4

Detailed Measured ED and Organ-Specific Dosimetry

	Estimated radiation dose (mSv/MBq)
	Subject
Target organ	1	2	3	4	5	6	Average	SD	Percentage coefficient of variation
Adrenals	1.48E–02	1.41E–02	1.49E–02	1.42E–02	1.54E–02	1.42E–02	1.46E–02	5.18E–04	3.55E+00
Brain	1.07E–02	9.98E–03	9.14E–03	1.01E–02	9.83E–03	9.42E–03	9.86E–03	5.46E–04	5.54E+00
Breasts	1.06E–02	9.96E–03	9.42E–03	1.01E–02	1.01E–02	9.55E–03	9.96E–03	4.26E–04	4.28E+00
Gallbladder wall	1.42E–02	1.47E–02	1.53E–02	1.51E–02	1.60E–02	1.43E–02	1.49E–02	6.77E–04	4.54E+00
Lower large intestine wall	1.37E–02	1.37E–02	1.20E–02	1.34E–02	1.18E–02	1.30E–02	1.29E–02	8.43E–04	6.52E+00
Small intestine	1.91E–02	1.32E–02	1.23E–02	1.31E–02	1.27E–02	1.26E–02	1.38E–02	2.60E–03	1.88E+01
Stomach wall	1.41E–02	1.29E–02	1.40E–02	1.34E–02	1.48E–02	1.38E–02	1.38E–02	6.47E–04	4.68E+00
Upper large intestine wall	1.35E–02	1.30E–02	1.23E–02	1.30E–02	1.28E–02	1.25E–02	1.29E–02	4.23E–04	3.29E+00
Heart wall	1.27E–02	1.21E–02	1.19E–02	1.24E–02	1.27E–02	1.18E–02	1.23E–02	3.93E–04	3.21E+00
Kidneys	1.39E–01	1.02E–01	1.03E–01	6.38E–02	6.85E–02	7.61E–02	9.21E–02	2.84E–02	3.08E+01
Liver	1.93E–02	4.03E–02	5.84E–02	4.75E–02	6.17E–02	4.27E–02	4.50E–02	1.52E–02	3.38E+01
Lungs	1.19E–02	1.13E–02	1.12E–02	1.16E–02	1.19E–02	1.11E–02	1.15E–02	3.52E–04	3.06E+00
Muscle	1.20E–02	1.14E–02	1.07E–02	1.15E–02	1.12E–02	1.10E–02	1.13E–02	4.47E–04	3.96E+00
Ovaries	1.39E–02	1.39E–02	1.22E–02	1.35E–02	1.20E–02	1.31E–02	1.31E–02	8.32E–04	6.35E+00
Pancreas	1.62E–02	1.49E–02	1.78E–02	1.57E–02	1.86E–02	1.69E–02	1.67E–02	1.37E–03	8.20E+00
Pituitary gland	1.31E–02	1.02E–01	2.42E–02	4.63E–02	2.49E–02	3.86E–02	4.16E–02	3.20E–02	7.70E+01
Hematopoietic cells	1.02E–02	9.67E–03	9.21E–03	9.68E–03	9.58E–03	9.32E–03	9.61E–03	3.47E–04	3.61E+00
Bone-forming cells	1.67E–02	1.57E–02	1.46E–02	1.58E–02	1.55E–02	1.49E–02	1.55E–02	7.39E–04	4.76E+00
Salivary glands	2.15E–03	2.27E–02	6.85E–03	1.30E–02	7.02E–03	1.85E–02	1.17E–02	7.82E–03	6.68E+01
Skin	1.03E–02	9.77E–03	9.09E–03	9.83E–03	9.63E–03	9.31E–03	9.66E–03	4.24E–04	4.39E+00
Spleen	2.01E–01	1.30E–01	3.95E–01	1.96E–01	4.15E–01	3.54E–01	2.82E–01	1.21E–01	4.28E+01
Testes	1.19E–02	1.18E–02	1.04E–02	1.16E–02	1.04E–02	1.11E–02	1.12E–02	6.78E–04	6.06E+00
Thymus	1.17E–02	1.10E–02	1.03E–02	1.11E–02	1.10E–02	1.05E–02	1.09E–02	4.93E–04	4.51E+00
Thyroid	2.54E–02	3.63E–02	9.93E–03	1.09E–02	1.07E–02	1.88E–02	1.87E–02	1.05E–02	5.65E+01
Urinary bladder wall	1.02E–01	1.90E–01	1.11E–01	1.49E–01	2.02E–02	1.76E–01	1.25E–01	6.18E–02	4.96E+01
Uterus (estimated)^*	1.51E–02	1.64E–02	1.36E–02	1.55E–02	1.21E–02	1.54E–02	1.47E–02	1.56E–03	1.06E+01
Total body	1.34E–02	1.31E–02	1.35E–02	1.33E–02	1.39E–02	1.32E–02	1.34E–02	2.83E–04	2.11E+00
ED	2.25E–02	2.43E–02	2.81E–02	2.49E–02	2.44E–02	3.02E–02	2.57E–02	2.85E–03	1.11E+01

↵* Uterus dosimetry is estimated because all subjects were men.